Figure 2From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicityPercentage of Vγ9/Vδ2 cells isolated from active patients cultured in presence of Infliximab (50 μg/ml). (a) Effector CD45RO+CD27-; (b) Cytotoxic CD45RO-CD27-; (c) Memory CD45RO+CD27+; naive CD45RO-CD27+.Back to article page